113 results
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
9 May 24
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
7:36pm
had $42.8 million of cash and cash equivalents, $106.8 million of short-term investments, and $8.8 million of long-term investments. In addition, in May … equivalents, short-term and long-term investments during the three months ended March 31, 2024, compared to the three months ended March 31, 2023.
Net
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
10 Aug 22
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:06pm
) Conference.
Long-term clinical data showing improvement in metabolic parameters and body composition following treatment with DCCR tablets in patients … ,
(Unaudited)
Assets
Current assets
Cash and cash equivalents
Prepaid expenses and other current assets
Total current assets
Long-term assets
Property
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
9 Nov 22
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:11pm
2022 and Recent Corporate Highlights
Initiated the randomized withdrawal period of Study C602, a long-term treatment study of DCCR (Diazoxide … showed that long term hyperphagia change from baseline was significantly associated with circulating drug levels, with greater improvements associated
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
9 May 23
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
Corporate Highlights
Completed enrollment in the randomized withdrawal period of Study C602, a long-term treatment study of Diazoxide Choline (DCCR … current assets
Long-term assets
Property and equipment, net
Operating lease right-of-use assets
Intangible assets, net
Other long-term assets
Total
8-K
EX-99.1
tj2z6ciuiaitf1a5o
12 May 20
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
bsw79bi q6fnbet7ak
15 Nov 18
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018
4:02pm
8-K
EX-99.1
e4gruevkcq83
18 Mar 19
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
4:37pm
8-K
EX-99.1
nj61dvz
5 May 21
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:01pm
8-K
EX-99.1
hq2mn7nq9og 2ta2js
7 Mar 24
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
6:06am
8-K
EX-99.1
hafaqaad7frpg5q
14 Aug 18
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results
4:22pm
8-K
EX-99.1
mtsr1282kplslyga
10 May 22
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:01pm
8-K
EX-99.1
w1k5ghh hi24s
10 Nov 20
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:22pm
8-K/A
EX-99.2
56t71i 6zukr1i
10 Apr 17
Other Events
12:00am
8-K
EX-99.1
aj9nsujx9jjdl3 4e
8 Aug 23
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:25pm
8-K
EX-99.1
wcc1txblqu4m8d
10 Aug 20
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:09pm
8-K
EX-99.1
r6nn3
16 May 18
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
6:08am
8-K
EX-99.1
l484x7qepxeylyazw5c
3 Mar 21
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year
4:01pm
8-K
EX-99.1
wakxbxr
13 Nov 19
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results
6:10am
8-K
EX-99.1
nqyapnkcbsxpql7p57
4 Mar 20
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
4:17pm